Cosmetic Peptides Australia: Powder vs Serum vs Topical
Research powder vs cosmetic serum
| Research powder | Cosmetic serum | |
|---|---|---|
| Product class | Laboratory material | Finished cosmetic |
| The number on it | Mass in mg, plus batch purity | A percentage of the formula |
| Formulation | None, compound only | Vehicle, preservatives, chelators |
| Concentration set by | You, at reconstitution | The formulator |
| Supplied by PhaseOne | Yes | No |
The cosmetic peptide category throws up more format confusion than any other, because the same ingredient name appears on three completely different things. A sealed vial of lyophilised research powder, a bottle of serum off a shelf, and a preparation made up by a compounding pharmacy are not interchangeable, and a figure from one does not translate to another.
This guide covers those three formats and what separates them, what the GHK-Cu literature actually used in dermal versus animal work, why a serum percentage will not compare against a vial concentration, and how the compounds in the category differ by mechanism. PhaseOne supplies research powder, and nothing here is guidance on applying or administering anything to a person.
On this page
Three formats | Powder vs serum | Topical GHK-Cu | Parenteral routes | Percentages vs mg per ml | GHK-Cu vs Melanotan II | The blends | Misconceptions | FAQs
Key points at a glance
- Research-grade powder, a retail cosmetic serum and a compounded preparation are three separate product classes, regulated differently and not substitutes for each other
- PhaseOne supplies lyophilised research powder in sealed vials, for laboratory research only
- A percentage on a serum label and a mg per ml figure from a reconstituted vial are different measurements and cannot be compared directly
- The GHK-Cu literature splits into dermal and cell-culture work on one side and animal parenteral work on the other, using different preparations and different units
- Neither literature converts into an amount for a person, and we do not publish administration guidance
- GHK-Cu and Melanotan II are grouped together by category convention only. They share no receptor or pathway
- GHK-Cu is the light-sensitive one in this category, because the copper complex is the fragile part
Three formats, one ingredient name
Most of the confusion in this category comes from the word GHK-Cu appearing on products that have almost nothing else in common.
| Format | What it is | Who it comes from |
|---|---|---|
| Research powder | Lyophilised compound in a sealed vial, stated mass, batch HPLC tested | A research supplier, for laboratory use |
| Cosmetic serum | A finished formulation with preservatives and a percentage on the label | A cosmetics retailer |
| Compounded preparation | Made up for one named person against a prescription | A compounding pharmacy, via a prescriber |
PhaseOne sits in the first column only. We supply GHK-Cu as research powder and have no cosmetic or compounded line. The practical consequence is that a number from our label, such as 50mg in a vial, is not comparable to a percentage on a serum bottle, and neither of them is a dose.
Research powder versus a copper peptide serum
A copper peptide serum is a cosmetic product. It has been formulated: the peptide sits in a vehicle alongside preservatives, chelators, humectants and whatever else the formulator chose, at a concentration the formulator decided, with stability engineered around that mix.
Research powder is the opposite. It is the compound, dry, in a known mass, with a batch purity figure behind it and nothing else in the vial. That makes it the right material for a controlled experiment and the wrong material to treat as a finished product, because every variable a serum has already settled is still open.
The GHK-Cu research guide goes into the mechanism and the copper chemistry. The point for format purposes is narrower: buying research powder does not get you a cheaper serum, and the two cannot be reasoned about with the same numbers.
Topical GHK-Cu: what the research used
Searches for topical GHK-Cu are usually asking whether the skin route is the simple option. The honest answer has two halves, and only one of them is about chemistry.
On the research side: a large part of the GHK-Cu literature is in cell culture and skin models, where the compound is presented in a vehicle at a stated concentration. Those studies establish what happens at the cells, under conditions the experimenter controlled. What they do not establish is how much of an applied amount crosses intact human skin, in what state, from an arbitrary preparation. Skin is a barrier, the copper complex is the fragile part of the molecule, and a vehicle that was never designed for delivery is not a delivery system.
On the practical side: we supply research powder and do not provide instructions for applying anything to a person. If the question is about using a copper peptide on skin, the product class designed and regulated for that is a cosmetic serum from a cosmetics retailer, not laboratory material from us. See the peptide legality guide for why that distinction matters beyond chemistry.
Parenteral routes in the literature
The other half of the GHK-Cu literature is animal work where the compound was given parenterally and dosed by body weight. Searches around GHK-Cu injection usually have this half in mind, or are reasoning backwards from what other research peptides are known for.
Three things are worth being clear about. These are animal studies, with doses expressed per kilogram of animal, in models chosen for the research question rather than to resemble human use. A figure from them does not convert into a human amount, and the arithmetic that looks like it should work does not. And the route used in a study is a feature of the experimental design, not a recommendation carried forward to anybody.
We do not publish administration guidance, dosing schedules or route recommendations for any compound in the range, in this category or any other. Our material ships as powder with a purity figure, and where the compound goes after that is governed by the researcher's own protocol and, if a person is involved, by a prescriber rather than by us.
Why a serum percentage will not compare
This trips up more comparisons than anything else in the category, and it is worth spelling out because the two numbers look superficially similar.
| Serum label | Reconstituted vial | |
|---|---|---|
| The number | A percentage, such as 1% or 3% | A mass per volume, such as 10mg per ml |
| What it measures | Share of the total formulation | Compound mass in the liquid |
| Who sets it | The formulator | You, by how much water you add |
| Purity behind it | Not usually stated | Batch HPLC figure |
| Tells you the delivered amount | No | No, it tells you the concentration |
So a 1% serum and a 10mg per ml reconstituted vial are not two points on one scale. One is a share of a mixture and the other is a concentration you chose. Neither is a delivered amount, and converting between them produces a number that means nothing. The reconstitution guide covers how vial concentration is actually set.
GHK-Cu and Melanotan II are not related
Both sit in this category by convention, and they have no mechanism in common. GHK-Cu is a copper-binding tripeptide whose activity depends on the copper coordination. Melanotan II is a synthetic cyclic analogue of alpha-MSH studied for melanocortin receptor agonism.
| GHK-Cu | Melanotan II | |
|---|---|---|
| Class | Copper-binding tripeptide | Cyclic alpha-MSH analogue |
| Studied at | Copper-dependent signalling | MC1R and MC4R |
| Formats in the wild | Powder, serum, compounded | Powder, compounded |
| Poisons Standard | No entry | Schedule 4 |
| Light sensitive | Yes, the copper complex | Not the defining concern |
The second row is the one that matters for reading research. A finding about one says nothing about the other, and Melanotan II's MC4R activity is a separate dimension again, unrelated to any pigmentation question. Note also the fourth row: the two compounds are not in the same regulatory position either, which the legality guide covers.
The GLOW and KLOW blends
Both blends are built on GHK-Cu alongside regenerative-category compounds, in one vial.
| Blend | Components | Vial |
|---|---|---|
| GLOW | BPC-157, TB-500, GHK-Cu | 70mg |
| KLOW | BPC-157, TB-500, GHK-Cu, KPV | 80mg |
A blend is a convenience for a protocol that genuinely wants the components together, and a complication for one that does not, because an outcome cannot be attributed to any single component. See the GLOW guide and the KLOW guide , or the regenerative peptide guide for the other compounds in them.
Handling: the copper complex is the fragile part
GHK-Cu is the compound in this category with a real handling constraint, and it comes from the chemistry rather than from the peptide being delicate. The activity depends on copper staying coordinated to the tripeptide, and that complex is light sensitive.
Keep sealed vials dark and refrigerated, keep reconstituted solution dark, and do not leave it sitting on a bench under light. The storage guide has the detail, and the bacteriostatic water guide covers what to reconstitute with.
What the research does not establish
The cosmetic category carries the same evidential gap as the rest of the research peptide space, and in some respects a wider one, because cosmetic claims are easy to make and hard to test.
The literature is concentrated in cell culture, skin models and animal studies. Human clinical evidence is limited. Nothing in it establishes an outcome for a person from an arbitrary preparation at an arbitrary amount by an arbitrary route, which is the gap most cosmetic peptide marketing quietly steps over.
Common misconceptions
That research powder is a cheaper version of a serum. It is a different product class. The serum has solved formulation, stability and delivery; the powder has not, because it was never meant to.
That a percentage and a mg per ml figure are comparable. They measure different things and converting between them produces a meaningless number.
That a dermal study concentration tells you what reaches the skin. It tells you the concentration in the vehicle the experimenter used, under conditions they controlled.
That an animal dose per kilogram scales to a person. It does not, and treating it as arithmetic is the most common error in this whole subject.
That GHK-Cu and Melanotan II are variations on a theme because they are sold alongside each other. They share no receptor, no pathway and not even the same regulatory status.
Verifying purity in this category
Every PhaseOne batch in the cosmetic category is tested by an independent laboratory using HPLC against a purity standard of ≥99%, and the result is published in the public COA library rather than enclosed with a vial or supplied on request.
Purity matters more than usual for GHK-Cu, because the figure is about the complex rather than a bare peptide chain, and because it is one of the few numbers in this category that means something precise. See the HPLC standards guide for how to read a certificate.
Related guides
For the compound itself, see the GHK-Cu research guide and the Melanotan II guide . For the blends, see GLOW and KLOW . For regulatory position, see the peptide legality guide . For handling, see the reconstitution guide and the storage guide .
Frequently Asked Questions
Is topical GHK-Cu the same as research-grade GHK-Cu?
No. A topical product is a formulated cosmetic with a vehicle, preservatives and a stated percentage. Research-grade GHK-Cu is dry powder in a sealed vial with a batch purity figure and nothing else in it.
Can I use research powder topically?
We supply it for laboratory research and do not provide instructions for applying anything to a person. If the goal is a copper peptide on skin, a cosmetic serum from a cosmetics retailer is the product class designed and regulated for that.
What does the topical GHK-Cu research actually show?
Cell culture and skin-model studies show effects at the cells at concentrations the experimenter controlled. They do not establish how much of an applied amount crosses intact human skin, or in what state.
Is GHK-Cu injected in studies?
Part of the literature is animal work given parenterally and dosed per kilogram of animal. That is an experimental design choice, not a recommendation, and the figures do not convert to a human amount.
Does PhaseOne provide dosing or route guidance?
No. For any compound in the range we supply powder with a batch purity figure. Protocol decisions belong to the researcher, and anything involving a person belongs to a prescriber.
Is a GHK-Cu serum better than a vial?
They are not on the same scale, so better does not apply. A serum is a finished cosmetic product. A vial is laboratory material. Which is appropriate depends entirely on what you are doing.
How does a 1% serum compare to 10mg per ml?
It does not compare. A percentage is a share of a whole formulation; mg per ml is mass in a volume that you set when reconstituting. Neither is a delivered amount.
What concentration do I get from a GHK-Cu vial?
Whatever you set. Concentration is a function of the vial mass and how much bacteriostatic water you add, which the reconstitution guide covers.
Why is a serum percentage not enough information?
Because it tells you the proportion in the mixture and nothing about purity, stability, how much is still intact or how much is delivered. A vial at least carries a batch purity figure.
What compounds are in the cosmetic category?
GHK-Cu and Melanotan II, plus the GLOW and KLOW blends which are built on GHK-Cu alongside regenerative-category compounds.
Do GHK-Cu and Melanotan II work the same way?
No. GHK-Cu's activity is copper-dependent. Melanotan II is an alpha-MSH analogue studied at MC1R and MC4R. They share no receptor or pathway.
Is Melanotan II only about pigmentation?
No. Its MC4R activity is a separate dimension of its profile, unrelated to any pigmentation question, and it is a defining part of the compound rather than a footnote.
Are GHK-Cu and Melanotan II in the same regulatory position?
No. Melanotan II is Schedule 4 in the Poisons Standard. GHK-Cu has no entry. The legality guide sets out what each of those means.
What is in GLOW and KLOW?
GLOW is BPC-157, TB-500 and GHK-Cu in a 70mg vial. KLOW adds KPV, in an 80mg vial.
Why would a blend be a problem for a protocol?
Because an outcome cannot be attributed to any single component. A blend suits a design that wants the components together and complicates one that needs attribution.
Why is GHK-Cu light sensitive?
Its activity depends on copper staying coordinated to the tripeptide, and that complex is the light-sensitive part. Keep vials and reconstituted solution dark.
Does GHK-Cu need different storage from Melanotan II?
It needs the extra light protection, because of the copper complex. Melanotan II does not carry that particular constraint.
Why does GHK-Cu appear in the regenerative category too?
Because the same copper-dependent mechanism is studied from a skin angle and a broader tissue angle. One mechanism, two research framings, not two mechanisms.
What purity does PhaseOne state for this category?
≥99% HPLC purity, tested independently batch by batch, with results published in the public COA library.
Where can I buy research-grade GHK-Cu in Australia?
PhaseOne supplies it as lyophilised powder in 50mg and 100mg vials, shipped Australia-wide from Sydney, for laboratory research only.
Disclaimer
All products supplied by PhaseOne are intended strictly for laboratory research purposes only. Products are not intended for human consumption, therapeutic use, cosmetic use, veterinary use, or diagnostic applications. Nothing on this page is administration, dosing or application guidance.
Research peptides related to this guide

GHK-Cu Australia 50mg / 100mg
from $55.99
Shop GHK-Cu Australia 50mg / 100mg →
GLOW Peptide Blend 70mg (BPC-157 + GHK-Cu + TB-500)
from $143.99
Shop GLOW Peptide Blend 70mg (BPC-157 + GHK-Cu + TB-500) →
KLOW Peptide Blend 80mg (BPC-157 + GHK-Cu + TB-500 + KPV)
from $163.19
Shop KLOW Peptide Blend 80mg (BPC-157 + GHK-Cu + TB-500 + KPV) →
Melanotan II Australia (MT2) 10mg
from $55.99
Shop Melanotan II Australia (MT2) 10mg →
Melanotan I Australia (MT1) 10mg
from $55.99
Shop Melanotan I Australia (MT1) 10mg →

